Phase 1, Open-label, Randomized, Single-dose, 2-treatment, 2-period, Crossover, Bioequivalence Study Comparing Phase 2b 1 Mg And 5 Mg Tablet Formulations Of Cp-690,550 Under Fasted Conditions.
Phase of Trial: Phase I
Latest Information Update: 06 Apr 2011
At a glance
- Drugs Tofacitinib (Primary)
- Indications Ankylosing spondylitis; Plaque psoriasis; Psoriatic arthritis; Renal transplant rejection; Rheumatoid arthritis; Ulcerative colitis
- Focus Pharmacokinetics
- 06 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jan 2011 New trial record